Matt Doherty

Post-doc since 2015

Research areas

  • Antibiotic Resistance
  • Therapeutic discovery/development
  • Crohn's disease
  • Microbial ecology
  • Microbial evolution
  • Science Education
  • Cancer

Education

  • BS: University of Notre Dame (2006)
  • PhD: University of California - Davis (2013)
Matt Doherty

Background

I’m a wet lab microbiologist learning computational microbiology while working to determine the effects of a novel Crohn’s disease therapy on the fecal microbiome. I am also trying to determine whether the fecal microbiome of these patients can be used as a biomarker to predict response to treatment. Previously I’ve researched antimicrobial resistance and novel therapies for HIV and MRSA.

Schloss lab papers

  1. Doherty MD, Ding T, Koumpouras C, Telesco SE, Monast C, Das A, Brodmerkel C, Schloss PD. 2018. Fecal microbiota signatures are associated with response to Ustekinumab therapy among Crohn’s Disease patients. mBio. 9: e02120-17. DOI: 10.1128/mBio.02120-17.